Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malcolm Finlayson

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|April 15, 2015
Modulation of CD44 Activity by A6-PeptideMalcolm Finlayson
Molecular Cancer Therapeutics|September 3, 2011
A6 peptide activates CD44 adhesive activity, induces FAK and MEK phosphorylation, and inhibits the migration and metastasis of CD44-expressing cellsRandolph S Piotrowicz, Bassam B Damaj, Mohamed Hachicha, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 24, 2022
Phase I trial of daily subcutaneous SPL-108 injections in combination with paclitaxel in patients with platinum resistant CD44+ advanced ovarian epithelial cancerEugenia Girda, June Hou, David Nelson, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|April 15, 2015
Modulation of CD44 Activity by A6-PeptideMalcolm Finlayson
Molecular Cancer Therapeutics|September 3, 2011
A6 peptide activates CD44 adhesive activity, induces FAK and MEK phosphorylation, and inhibits the migration and metastasis of CD44-expressing cellsRandolph S Piotrowicz, Bassam B Damaj, Mohamed Hachicha, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 24, 2022
Phase I trial of daily subcutaneous SPL-108 injections in combination with paclitaxel in patients with platinum resistant CD44+ advanced ovarian epithelial cancerEugenia Girda, June Hou, David Nelson, et al.
Pageof 1